143 related articles for article (PubMed ID: 29269214)
1. Synthesis and biological evaluation of novel mono- and bivalent ASGP-R-targeted drug-conjugates.
Petrov RA; Maklakova SY; Ivanenkov YA; Petrov SA; Sergeeva OV; Yamansarov EY; Saltykova IV; Kireev II; Alieva IB; Deyneka EV; Sofronova AA; Aladinskaia AV; Trofimenko AV; Yamidanov RS; Kovalev SV; Kotelianski VE; Zatsepin TS; Beloglazkina EK; Majouga AG
Bioorg Med Chem Lett; 2018 Feb; 28(3):382-387. PubMed ID: 29269214
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel doxorubicin-containing ASGP-R-targeted drug-conjugates.
Ivanenkov YA; Majouga AG; Petrov RA; Petrov SA; Kovalev SV; Maklakova SY; Yamansarov EY; Saltykova IV; Deyneka EV; Filkov GI; Kotelianski VE; Zatsepin TS; Beloglazkina EK
Bioorg Med Chem Lett; 2018 Feb; 28(3):503-508. PubMed ID: 29254645
[TBL] [Abstract][Full Text] [Related]
3. A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy.
Li SS; Zhang CM; Wu JD; Liu C; Liu ZP
Eur J Med Chem; 2022 Jan; 228():114037. PubMed ID: 34883290
[TBL] [Abstract][Full Text] [Related]
4. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
[TBL] [Abstract][Full Text] [Related]
5. N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma.
Li T; Yu P; Chen Y; Sun B; Dong P; Zhu T; Meng X
Eur J Med Chem; 2021 Oct; 222():113605. PubMed ID: 34126457
[TBL] [Abstract][Full Text] [Related]
6. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
7. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
Zhang T; Li G; Li S; Wang Z; He D; Wang Y; Zhang J; Li J; Bai Z; Zhang Q; Liu B; Zhao Q; Liu Y; Zhang H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110397. PubMed ID: 31357127
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of small molecules targeting paclitaxel-induced MyD88 expression in triple-negative breast cancer cell lines.
Poh Yen K; Stanslas J; Zhang T; Li H; Wang X; Kok Meng C; Kok Wai L
Bioorg Med Chem; 2021 Nov; 49():116442. PubMed ID: 34600241
[TBL] [Abstract][Full Text] [Related]
9. Functionalized micelles from block copolymer of polyphosphoester and poly(epsilon-caprolactone) for receptor-mediated drug delivery.
Wang YC; Liu XQ; Sun TM; Xiong MH; Wang J
J Control Release; 2008 May; 128(1):32-40. PubMed ID: 18395283
[TBL] [Abstract][Full Text] [Related]
10. Efficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactions.
Ding J; Xiao C; Li Y; Cheng Y; Wang N; He C; Zhuang X; Zhu X; Chen X
J Control Release; 2013 Aug; 169(3):193-203. PubMed ID: 23247039
[TBL] [Abstract][Full Text] [Related]
11. Response Surface Methodology to Optimize the Combination Treatment of Paclitaxel, Bufalin and Cinobufagin for Hepatoma Therapy.
Zhang J; Shu C; Yi X; Zhu J; Lian X; Wu Y
Comb Chem High Throughput Screen; 2021; 24(10):1727-1735. PubMed ID: 33172373
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.
Li J; Yin T; Wang L; Yin L; Zhou J; Huo M
Int J Pharm; 2015 Apr; 483(1-2):38-48. PubMed ID: 25655715
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
Jin X; Mo R; Ding Y; Zheng W; Zhang C
Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
[TBL] [Abstract][Full Text] [Related]
14. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma.
Petrov RA; Mefedova SR; Yamansarov EY; Maklakova SY; Grishin DA; Lopatukhina EV; Burenina OY; Lopukhov AV; Kovalev SV; Timchenko YV; Ondar EE; Ivanenkov YA; Evteev SA; Vaneev AN; Timoshenko RV; Klyachko NL; Erofeev AS; Gorelkin PV; Beloglazkina EK; Majouga AG
Mol Pharm; 2021 Jan; 18(1):461-468. PubMed ID: 33264010
[TBL] [Abstract][Full Text] [Related]
15. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma.
Huang KW; Lai YT; Chern GJ; Huang SF; Tsai CL; Sung YC; Chiang CC; Hwang PB; Ho TL; Huang RL; Shiue TY; Chen Y; Wang SK
Biomacromolecules; 2018 Jun; 19(6):2330-2339. PubMed ID: 29808997
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 2'-paclitaxel 2-deoxy-2-fluoro-glucopyranosyl carbonate for specific targeted delivery to cancer cells.
Meng X; Lian X; Li X; Ya Q; Li T; Zhang Y; Yang Y; Zhang Y
Carbohydr Res; 2020 Jul; 493():108034. PubMed ID: 32485481
[TBL] [Abstract][Full Text] [Related]
17. Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
Villa R; Cerroni B; Viganò L; Margheritelli S; Abolafio G; Oddo L; Paradossi G; Zaffaroni N
Colloids Surf B Biointerfaces; 2013 Oct; 110():434-42. PubMed ID: 23759384
[TBL] [Abstract][Full Text] [Related]
18. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.
Lv J; Sun H; Zou Y; Meng F; Dias AA; Hendriks M; Feijen J; Zhong Z
Biomater Sci; 2015 Jul; 3(7):1134-46. PubMed ID: 26221946
[TBL] [Abstract][Full Text] [Related]
19. Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery.
Sun Y; Zhang J; Han J; Tian B; Shi Y; Ding Y; Wang L; Han J
AAPS PharmSciTech; 2017 Apr; 18(3):749-758. PubMed ID: 27287244
[TBL] [Abstract][Full Text] [Related]
20. Identification of Novel Small-Molecule ASGP-R Ligands.
Majouga AG; Ivanenkov YA; Veselov MS; Lopuhov AV; Maklakova SV; Beloglazkina EK; Binevski PV; Klyachko NL; Sandulenko YB; Galkina NY; Koteliansky VE
Curr Drug Deliv; 2016; 13(8):1303-1312. PubMed ID: 27440073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
